What is the recommended loading dose and administration rate for phenytoin (Dilantin) in a patient with seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended loading dose of phenytoin (Dilantin) for seizures is 20 mg/kg divided in maximum doses of 400 mg every 2 h orally, or 18 mg/kg IV at a maximum rate of 50 mg/min. For a typical adult, this translates to approximately 1000-1500 mg total when administered intravenously. The medication should be administered in normal saline (not dextrose solutions, which can cause precipitation) through a large vein using an in-line filter 1. Some key points to consider when administering phenytoin include:

  • Continuous cardiac monitoring is necessary during administration due to the risk of hypotension and cardiac arrhythmias.
  • Blood pressure should be checked every 5-10 minutes during the infusion.
  • Following the loading dose, maintenance therapy typically begins 12 hours later at 4-6 mg/kg/day (usually 300-400 mg/day for adults), divided into 2-3 doses.
  • Phenytoin works by blocking voltage-sensitive sodium channels in neurons, which limits repetitive firing of action potentials and prevents seizure propagation.
  • Therapeutic drug monitoring is important, with a target serum concentration of 10-20 mcg/mL.
  • Patients should be monitored for adverse effects including cardiac complications, hypotension, and infusion site reactions 1. It's also worth noting that fosphenytoin, a pro-drug of phenytoin, can be used as an alternative with a potentially better safety profile, especially regarding local and systemic adverse effects 1.

From the FDA Drug Label

For Status Epilepticus and Non-emergent Loading Dose: Adult loading dose is 10 to 15 mg/kg at a rate not exceeding 50 mg/min. ( 2 SECT 2.2) Pediatric loading dose is 15 to 20 mg/kg at a rate not exceeding 1 to 3 mg/kg/min or 50 mg/min, whichever is slower. ( 2 SECT 2. 8)

The recommended loading dose for phenytoin (Dilantin) in a patient with seizures is:

  • Adults: 10 to 15 mg/kg
  • Pediatrics: 15 to 20 mg/kg The recommended administration rate is:
  • Not exceeding 50 mg/min for adults
  • Not exceeding 1 to 3 mg/kg/min or 50 mg/min, whichever is slower, for pediatrics 2

From the Research

Phenytoin Loading Dose

  • The recommended loading dose for phenytoin is 18 mg/kg, administered as a solution of 500 mg phenytoin in 50 mL normal saline using a constant infusion pump 3.
  • The initial delivery rate can be 40 mg/min, but it may need to be reduced to 20 mg/min in some cases to relieve discomfort at the IV infusion site 3.
  • Therapeutic phenytoin blood levels (greater than 10 micrograms/mL) can be achieved in most patients (97%) with this loading dose 3.

Administration Rate

  • The administration rate of phenytoin can be adjusted based on the patient's response and tolerance to the medication 3.
  • A study compared the effectiveness of three phenytoin-loading techniques, including intravenous phenytoin at an initial infusion rate of 50 mg/min, and found that it was effective in achieving therapeutic drug concentrations quickly 4.
  • Another study found that estimating weight in children for the 20 mg/kg intravenous loading dose of phenytoin can be inaccurate, resulting in up to 138% of the expected and recommended dose 5.

Safety and Efficacy

  • Phenytoin has been associated with fatal haemodynamic complications and serious reactions at the injection site, including skin necrosis and amputation of extremities 6.
  • Fosphenytoin, a phenytoin prodrug, has the same pharmacological properties as phenytoin but none of the injection site and cardiac rhythm complications of intravenous infusions of phenytoin 7, 6.
  • The incidence of purple glove syndrome is less frequent with fosphenytoin than with phenytoin 7.
  • Supra-therapeutic serum concentrations of phenytoin can occur, especially when estimating weight in children, and can be associated with adverse effects consistent with phenytoin toxicity 5.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.